Edesa Biotech Inc (EDSA)
4.47
-0.04
(-0.89%)
USD |
NASDAQ |
May 16, 16:00
4.47
0.00 (0.00%)
After-Hours: 20:00
Edesa Biotech Total Return Level: 4.51 for May 15, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 15, 2024 | 4.51 |
May 14, 2024 | 4.53 |
May 13, 2024 | 4.435 |
May 10, 2024 | 4.61 |
May 09, 2024 | 4.514 |
May 08, 2024 | 4.55 |
May 07, 2024 | 4.52 |
May 06, 2024 | 4.48 |
May 03, 2024 | 4.632 |
May 02, 2024 | 4.555 |
May 01, 2024 | 4.452 |
April 30, 2024 | 4.443 |
April 29, 2024 | 4.37 |
April 26, 2024 | 4.420 |
April 25, 2024 | 4.468 |
April 24, 2024 | 4.31 |
April 23, 2024 | 4.465 |
April 22, 2024 | 4.38 |
April 19, 2024 | 4.45 |
April 18, 2024 | 4.36 |
April 17, 2024 | 4.40 |
April 16, 2024 | 4.346 |
April 15, 2024 | 4.16 |
April 12, 2024 | 4.480 |
April 11, 2024 | 4.48 |
Date | Value |
---|---|
April 10, 2024 | 4.685 |
April 09, 2024 | 4.540 |
April 08, 2024 | 4.65 |
April 05, 2024 | 4.675 |
April 04, 2024 | 4.800 |
April 03, 2024 | 4.36 |
April 02, 2024 | 4.40 |
April 01, 2024 | 4.24 |
March 28, 2024 | 4.192 |
March 27, 2024 | 4.45 |
March 26, 2024 | 4.12 |
March 25, 2024 | 4.178 |
March 22, 2024 | 4.28 |
March 21, 2024 | 4.09 |
March 20, 2024 | 4.32 |
March 19, 2024 | 4.11 |
March 18, 2024 | 4.30 |
March 15, 2024 | 4.39 |
March 14, 2024 | 4.36 |
March 13, 2024 | 4.33 |
March 12, 2024 | 4.55 |
March 11, 2024 | 4.56 |
March 08, 2024 | 4.528 |
March 07, 2024 | 4.35 |
March 06, 2024 | 4.315 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
2.55
Minimum
Nov 13 2023
83.44
Maximum
Sep 20 2021
24.48
Average
22.40
Median
Jun 08 2020
Total Return Level Benchmarks
Acasti Pharma Inc | 2.70 |
Aurinia Pharmaceuticals Inc | 5.31 |
Lexaria Bioscience Corp | 3.08 |
Xenon Pharmaceuticals Inc | 40.45 |
ESSA Pharma Inc | 6.20 |